Mark Landers
Senior Vice President, Biopharma Saga Diagnostics
Seminars
Thursday 5th February 2026
Pathlight MRD Finding the Right Patients Faster
2:50 pm
- SAGA has commercialized Pathlight MRD in early breast cancer and CRC
- We continue to expand Pathlight's footprint across the patient journey but into new indications
- We are further expanding our reach by offering Pathlight MRD for clinical trial referrals, enrollment and global deployment
